Starpharma

About:

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is an ASX 300 company and is a world leader in the development of dendrimer products.

Website: http://www.starpharma.com

Twitter/X: starpharma_asx

Description:

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is an ASX 300 company and is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications. Starpharma’s underlying technology is built around dendrimers – a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical and medical uses. Starpharma has three core development programs: VivaGel® portfolio, DEP™ drug delivery, and agrochemicals with the Company developing a number of products internally and others via commercial partnerships.

Total Funding Amount:

45M AUD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Midland, Michigan, United States

Founded Date:

1996-01-01

Contact Email:

info(AT)starpharma.com

Founders:

John Raff

Number of Employees:

11-50

Last Funding Date:

2020-09-30

IPO Status:

Public

Industries:

© 2025 bioDAO.ai